Skip to main content

Table 8 Relation between GSMD and VEGF with progression-free survival and overall survival among malignant pleural effusion group

From: Role of GSDMD and VEGF in differentiating between malignant and non-malignant pleural effusions

Studied variables

GSDMD

Log-rank P value

 ≤ 3.51

˃3.51

Median

Std. Error

95% CI Lower – upper

Median

Std. Error

95% CI Lower – upper

Progression-free survival

8.00

3.15

1.82 – 14.1

4.00

0.57

2.86 – 14.1

5.15 0.023*

Overall survival

14.0

0.351

13.9 – 15.3

13.0

1.37

10.9 – 16.3

2.58 0.108

Studied variables

GSDMD

Log-rank P value

 ≤ 256.4

 > 256.4

Median

Std. Error

95% CI Lower – upper

Median

Std. Error

95% CI Lower – upper

Progression-free survival

13.0

5.02

3.15 – 22.8

4.00

0.63

2.76 – 5.24

9.06 0.003*

Overall survival

13.0

0.583

12.9 – 15.2

10.0

1.56

10.6 – 16.8

0.843 0.359

  1. St. Error Standard error, CI Confidence interval *Significant